Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
453.70    -5.90 (-1.28%)
Bid:
454.70
Ask:
454.90
Spread: 0.20 (0.044%)
Market Cap: £5.65b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Trading Statement

5 May 2022 07:00

RNS Number : 3655K
Melrose Industries PLC
05 May 2022
 

 

 

 

 

 

5 May 2022

 

 

 

MELROSE INDUSTRIES PLC

 

AGM Trading Statement

 

Melrose Industries PLC ("Melrose" or the "Group") publishes the following trading update for the four months from 1 January to 30 April 2022 (the "Period") ahead of its Annual General Meeting taking place later today.

 

Group trading

 

Trading is in line with expectations for the year. Consistent with industry trends, the Aerospace division is experiencing continued growth with with like-for-like sales up 6% and the Automotive and Powder Metallurgy divisions remaining constrained by supply, with combined like-for-like sales down 4%, significantly below underlying consumer demand levels.

 

The Melrose Board is confident that the well advanced restructuring actions ensure all its businesses are positioned to deliver their full potential as supply constraints ease. In addition substantial progress has been made in recovering inflation. Due to the time lag effect the financial performance will be second half weighted, but Melrose is confident the impact of inflation can be offset by the measures taken.

 

Investor Day

 

Melrose will be holding an Investor Day on GKN Aerospace on 8 June, starting at 2.30pm, to explain in more detail the full potential for the business including growth and improvement opportunities, excellent long-term cash flow dynamics and new sustainable technology.

 

 

Simon Peckham, CEO of Melrose Industries PLC, said:

 

"Your Group continues to make good progress whilst dealing with the broader world challenges. We are increasingly seeing growth return to our Aerospace business, which is being rapidly well positioned for its future, and are confident of demonstrating the full quality of our largely restructured automotive businesses. We are well set to realise shareholder value as conditions improve."

 

-ends-

 

Enquiries:

Montfort Communications: Nick Miles

+44 (0) 20 3514 0897 / +44 (0) 7739 701 634

miles@montfort.london

 

Charlotte McMullen

+44 (0) 20 3514 0897 / +44 (0) 7921 881 800

mcmullen@montfort.london

 

Melrose Investor Relations: Chris Dyett

+44 (0) 7974 974690

ir@melroseplc.net

 

 

Melrose Industries PLC Stratton House 5 Stratton Street London W1J 8LA Tel: 020 7647 4500 Fax: 020 7647 4501

 

Registered in England & Wales Registered no: 09800044 Registered office: 11th floor The Colmore Building Colmore Circus Queensway Birmingham West Midlands B4 6AT 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZLFBLELBBBZ
Date   Source Headline
22nd Jul 20207:00 amRNSTrading Statement
4th Jun 20202:36 pmRNSDirector/PDMR Shareholding
28th May 20207:00 amRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
7th May 202012:56 pmRNSResult of AGM
7th May 20207:00 amRNSTrading Statement
6th May 20204:56 pmRNSHolding(s) in Company - Replacement
5th May 20204:10 pmRNSHolding(s) in Company
5th May 20204:09 pmRNSHolding(s) in Company
4th May 20207:00 amRNSHolding(s) in Company
1st May 20205:05 pmRNSHolding(s) in Company
28th Apr 20205:02 pmRNSRegulatory Filing – LR.9.2.6E
15th Apr 202011:03 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 202011:04 amRNSAnnual Report and Notice of AGM
31st Mar 20209:57 amRNSStandard annual confirmation of POUs
30th Mar 20204:25 pmRNSTrading Statement
19th Mar 20209:42 amRNSHolding(s) in Company
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
13th Mar 20203:33 pmRNSHolding(s) in Company
10th Mar 20209:46 amRNSDirector/PDMR Shareholding
9th Mar 202011:13 amRNSDirector/PDMR Shareholding
9th Mar 20207:00 amRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFinal Results
19th Nov 20197:00 amRNSTrading Statement
18th Oct 20194:30 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSAppointment of Independent Non-Executive Director
5th Sep 20197:00 amRNSHalf-year Report
14th Jun 20194:00 pmRNSDirector/PDMR Shareholding
29th May 20194:04 pmRNSDirector/PDMR Shareholding
9th May 201912:49 pmRNSResult of AGM
9th May 20197:00 amRNSTrading Statement
5th Apr 201912:55 pmRNS2018 Annual Report and Notice of AGM
3rd Apr 20191:20 pmRNSCapital Markets Day
1st Apr 20195:43 pmRNSPost-Offer Undertakings Report
18th Mar 20194:41 pmRNSDirector/PDMR Shareholding
11th Mar 20195:01 pmRNSDirector/PDMR Shareholding
7th Mar 20197:00 amRNSFinal Results
6th Mar 20197:00 amRNSSundry Disposals
19th Dec 20187:00 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSTrading Statement
19th Oct 20183:27 pmRNSAmended Holding(s) in Company
19th Oct 20181:46 pmRNSHolding(s) in Company
17th Oct 20184:47 pmRNSDirector/PDMR Shareholding
8th Oct 201810:30 amRNSAppointment
4th Oct 20184:19 pmRNSDirector/PDMR Shareholding
1st Oct 20187:00 amRNSAppointment of Director
6th Sep 20187:00 amRNSHalf-year Report
28th Aug 20183:55 pmRNSHolding(s) in Company
28th Aug 20182:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.